Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
246
-
Total 13F shares, excl. options
-
10.5M
-
Shares change
-
-144K
-
Total reported value, excl. options
-
$1.69B
-
Value change
-
-$6.56M
-
Put/Call ratio
-
0.76
-
Number of buys
-
133
-
Number of sells
-
-105
-
Price
-
$160.16
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q2 2018
279 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q2 2018.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.5M shares
of 10.9M outstanding shares and own 96.51% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.54M shares), RENAISSANCE TECHNOLOGIES LLC (993K shares), VANGUARD GROUP INC (984K shares), DIMENSIONAL FUND ADVISORS LP (691K shares), ACADIAN ASSET MANAGEMENT LLC (454K shares), STATE STREET CORP (355K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (231K shares), TEACHERS ADVISORS, LLC (192K shares), Bank of New York Mellon Corp (174K shares), and Man Group plc (170K shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.